Articles from Pharma (January 1, 2008)

1-43 out of 43 article(s)

Title	Author	Type	Words
A new regulatory approach to nebuliser testing: a new Pharmacopoeial monograph reflects the changes triggered by the decision of the EMEA (European Medicines Agency) to issue regulatory guidance on the drug delivery aspects of nebulisers. Mark Copley from Copley Scientific reviews the monograph.	Copley, Mark		607
Al wins award.		Brief article	276
API China, a leading exhibition for China's entire pharmaceutical manufacturing sector, enjoyed a robust turnout during the three-day show in Shenzhen from 13-15 November 2007.		Brief article	277
Assays speed up bacterial identification.			188
Bank charges: a hard pill to swallow for pharma: bank charges cost the pharma industry hundreds of thousands of pounds a year and UK pharmaceutical companies are spending half a million pounds to recover missing funds, so Peter Burridge Managing Director of foreign exchange experts Travelex, says.	Burridge, Peter	Guest editorial	316
Billion dollar injection.		Brief article	271
Charged results: effective cleaning of 'disposable' pipette tips can save a company upwards of $0.5 million, but for a pipette tip cleaning system to be considered, its validity must be guaranteed. With an ARTEL MVS system, Cerionx believes they can offer that guarantee.			1620
Chimerix, Inc.		Brief article	116
Consolidation moves eastwards: while the merger of Hungarian firm Gedeon Richter and Polish firm Polpharma--both leading players in the pharmaceutical market in Central and Eastern Europe--demonstrates that the era of consolidation is not yet over, the focus is now moving eastwards and the markets of Romania, Ukraine and Russia are offering some interesting opportunities.			916
Critical sample anaysis: Andrew Parker, Molecular Profiles, reviews the use of 3D sample analysis using X-ray micro computer tomography.	Parker, Andrew		1616
Double-digit growth, but markets unimpressed.		Brief article	217
FDA approves Tysabri.		Brief article	291
Hello from me.	Lampard, Graham	Brief article	282
Leukaemia: where parent pressure succeeded.			872
Maik W. Jornitz becomes Chair-Elect PDA.		Brief article	193
MorphoSys and Novartis forge strategic alliance.		Brief article	267
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) has started a Phase II clinical trial evaluating the Company's PYY3-36 nasal spray in obese patients.			438
Novel microplate optimized for chemiluminescent assays.			299
Oxoid, a world leader in microbiology, has acknowledged the excellent work of a young microbiologist at the University of Brighton.		Brief article	149
Packaging agreement is just the tonic.			370
Pfizer Inc. (NYSE:PFE) and Scil Technology GmbH (Scil) have signed a licensing agreement for worldwide collaboration on Scil's cartilage specific growth factor CD-RAP.		Brief article	213
Pharmaceutical Profiles.		Brief article	146
PI for antibody to oxLDL.		Brief article	240
Porter Novelli Life Sciences.		Brief article	104
Preventing late stage failure due to genotoxic liabilities: speaking at the recent World Drug Discovery and Development Summit in Cologne, former VP of UK Safety Assessment at GSK, David Tweats, and Professor of Genetics at University of Manchester Richard Walmsley, looks at the issues in reducing late stage failures due to genotoxic liabilities.	Tweats, David; Walmsley, Richard		1623
Problem capped.		Brief article	255
Protagen raises 1 million [euro].		Brief article	166
Restructuring crunch: after the recent restructuring announcements by GlaxoSmithKline, AstraZeneca and Pfizer, and with redundancies a real possibility, Brigit Foster, Employment Solicitor at Darbys Solicitors LLP in Oxford, UK, outlines the basic relevant employment law for both employees and employers.	Foster, Brigit		888
Rugby stars slip into something more comfortable for charity.		Brief article	101
RVS: the future of filling.	Robinson, Kevin	Interview	1537
SAFC Pharma to increase manufacturing capacity.		Brief article	169
Sanyo biomedical solutions incubator.			307
SEMinal particle morphology analysis.	Fillion, Joe		1272
Simulating DPI devices: John Favier, CEO DEM, discusses the technical specifications required for software to study dry powder inhalation, and how to pmrove their DPI design.	Favier, John		1234
Solid packaging protection: new approaches to packaging protection for solid-dose drug formulations are discussed by Adrian Possumato from Multisorb Technologies.	Possumato, Adrian		990
Success for unique treatment of childhood malaria.			397
Survival of the fittest: Vicki Tauscher Phelan from EquaTerra reviews how pharmaceutical companies are adapting their outsourcing strategy in response to the threat of competition.	Phelan, Vicki Tauscher		825
The poll of 200 major pharmaceutical companies was conducted by the journal Industria Farmaceutica for the 'Best for quality and technical innovation' in 2007.		Brief article	136
Time to change: NostraPharmus predicts that a more strategic and proactive approach to safety will win back consumer confidence.			749
To trace or not to trace: that is not the question.			1778
Variety is the spice of life--for niche market sectors: six trade shows in one venue may be a lot to take in, but Mark Temple-Smith, Events Director for Canon Communications, believes that such variety can be effective.	Temple-Smith, Mark		769
VITRONIC new production facility.		Brief article	181
West expands in the South-West.		Brief article	229